LADYBARN GROUP PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: P84017 | MANCHESTER, M20 4SS
Showing results 501-550 of 637
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Riluzole | 20 | 266 | £1.5K | +92.7% ▲ |
| Levonorgestrel | 20 | 1,764 | £45 | +146.0% ▲ |
| Anastrozole | 20 | 728 | £28 | -78.0% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 20 | 356.0K | £9.3K | +44.9% ▲ |
| Nepafenac | 20 | 100 | £284 | +222.1% ▲ |
| Benzalkonium chloride | 20 | 5,000 | £112 | +74.4% ▲ |
| 20 | 3,012 | £307 | -1.1% vs avg | |
| Linaclotide | 19 | 532 | £678 | +4.0% ▲ |
| Chlortalidone | 19 | 426 | £830 | +92.6% ▲ |
| Ferrous gluconate | 19 | 1,148 | £33 | -60.3% ▼ |
| Betamethasone sodium phosphate | 19 | 210 | £47 | -26.7% ▼ |
| Ivermectin | 19 | 1,350 | £785 | -10.6% ▼ |
| 19 | 105 | £42 | -34.4% ▼ | |
| 19 | 960 | £655 | +70.8% ▲ | |
| 19 | 2,350 | £486 | +89.2% ▲ | |
| 19 | 1,560 | £4.4K | +28.4% ▲ | |
| 19 | 460 | £1.1K | +102.2% ▲ | |
| Olmesartan medoxomil/amlodipine | 18 | 504 | £290 | +36.5% ▲ |
| Eslicarbazepine acetate | 18 | 2,702 | £2.4K | -19.3% ▼ |
| Testosterone esters | 18 | 69 | £161 | +22.1% ▲ |
| Somatropin | 18 | 48 | £15.3K | +27.0% ▲ |
| Sodium chloride | 18 | 2,580 | £321 | -23.9% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 18 | 84.3K | £936 | -3.9% ▼ |
| Emulsifying wax | 18 | 9,000 | £136 | +47.8% ▲ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 17 | 700 | £403 | +7.5% ▲ |
| Inclisiran | 17 | 17 | £822 | +34.9% ▲ |
| Icosapent | 17 | 1,784 | £2.1K | -10.4% ▼ |
| Salmeterol | 17 | 17 | £473 | -29.3% ▼ |
| Urine testing reagents | 17 | 850 | £49 | +52.0% ▲ |
| Potassium chloride | 17 | 1,780 | £183 | -9.1% ▼ |
| Powder amino acid formula (0913107) | 17 | 60.8K | £3.9K | -48.5% ▼ |
| RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) | 17 | 3,240 | £3.7K | +75.3% ▲ |
| Powder single L-amino acid supplement (0913213) | 17 | 1,410 | £3.9K | +9.7% ▲ |
| Etoricoxib | 17 | 567 | £119 | -78.9% ▼ |
| Diclofenac sodium | 17 | 570 | £145 | -66.5% ▼ |
| Tizanidine hydrochloride | 17 | 2,604 | £112 | -35.8% ▼ |
| Diclofenac sodium | 17 | 1,100 | £801 | -29.1% ▼ |
| 17 | 70 | £255 | +91.2% ▲ | |
| 17 | 524 | £44 | +24.4% ▲ | |
| 17 | 1,020 | £3.2K | +54.1% ▲ | |
| Olmesartan medoxomil/hydrochlorothiazide | 16 | 1,176 | £569 | +61.4% ▲ |
| 16 | 260 | £338 | -59.4% ▼ | |
| 16 | 3,200 | £30 | -36.4% ▼ | |
| 16 | 90 | £2.7K | -55.2% ▼ | |
| 16 | 1,520 | £1.1K | -51.6% ▼ | |
| Metolazone | 15 | 84 | £366 | +112.6% ▲ |
| Bempedoic acid/Ezetimibe | 15 | 252 | £475 | -75.4% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 15 | 1,070 | £1.5K | +35.9% ▲ |
| Aspirin | 15 | 402 | £94 | +52.6% ▲ |
| Analgesics with anti-emetics | 15 | 360 | £121 | +6.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.